GlassScriptPhysician profile
Jonathan Solaimanzadeh
NPI 1386135036
$4,443.15
in general payments reported to CMS, 2019-2025
31 companies · $2,449 in 2025
The $2,449 reported for 2025 was more than what 95% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $671 · 2024: $1,323 · 2025: $2,449.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,443.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,443.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $640.98 | 2024-2025 | Wegovy, Ozempic, Saxenda |
| Janssen Pharmaceuticals, INC | $484.41 | 2023-2025 | Spravato, Xarelto |
| Astrazeneca Pharmaceuticals LP | $424.90 | 2023-2025 | Farxiga, Breztri, Lokelma |
| Axsome Therapeutics, INC. | $292.14 | 2025 | Auvelity |
| Boehringer Ingelheim Pharmaceuticals, INC. | $277.66 | 2023-2025 | Jardiance |
| Otsuka America Pharmaceutical, INC. | $259.44 | 2023-2025 | Rexulti |
| Exact Sciences Corporation | $254.17 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Pfizer INC. | $196.45 | 2024-2025 | |
| Novartis Pharmaceuticals Corporation | $181.38 | 2023-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $177.52 | 2025 | |
| Shield Therapeutics INC | $174.32 | 2023-2025 | Accrufer |
| Ipsen Biopharmaceuticals, INC | $125.00 | 2023 | Tazverik |
| Amgen INC. | $114.13 | 2023-2025 | Repatha, Repatha |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $100.80 | 2023-2025 | Xifaxan, Trulance |
| Esperion Therapeutics, INC. | $78.10 | 2023-2025 | Nexletol |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $78.02 | 2023-2025 | Jardiance, Zepbound, Mounjaro |
| E.R. Squibb & Sons, L.L.C. | $75.18 | 2023-2024 | Eliquis |
| Eisai INC. | $68.32 | 2023-2025 | |
| Merck Sharp & Dohme LLC | $68.21 | 2024-2025 | Gardasil 9, Capvaxive, Gardasil |
| Mylan Specialty L.P. | $62.11 | 2023-2024 | Yupelri |
| Boston Scientific Corporation | $58.20 | 2023-2025 | Watchman Flx |
| Medicomp INC | $38.13 | 2025 | Telepatch Cardiac Monitor |
| Currax Pharmaceuticals LLC | $31.00 | 2025 | Contrave |
| Alnylam Pharmaceuticals INC. | $28.01 | 2024 | Amvuttra |
| Dynavax Technologies Corporation | $26.85 | 2024 | Heplisav-B |
| Inspire Medical Systems, INC. | $25.03 | 2024 | Inspire |
| Teva Pharmaceuticals USA, INC. | $24.18 | 2025 | Austedo Xr |
| Lundbeck LLC | $21.02 | 2025 | Rexulti |
| Abbvie INC. | $20.03 | 2024 | |
| Kestra Medical Technology Services, INC. | $19.98 | 2025 | Assure Wcd |
| Corium, LLC | $17.48 | 2024 | Azstarys |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Solaimanzadeh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.